FDA Inspection 1005792 — Bergen Community Regional Blood Center
The FDA completed an inspection of Bergen Community Regional Blood Center on March 7, 2017 in Lincoln Park, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 7, 2017
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Lincoln Park, NJ (United States)